Functionality of albumin-derived perfluorocarbon-based artificial oxygen carriers in the Langendorff-heart .
Artif Cells Nanomed Biotechnol
; 45(4): 723-730, 2017 Jun.
Article
in En
| MEDLINE
| ID: mdl-28278587
ABSTRACT
The aim of this study was to prove whether albumin-derived perfluorocarbon-based nanoparticles (capsules) can operate as a novel artificial oxygen carrier in a rat Langendorff-heart perfusion model. Hearts perfused with capsules showed increased left ventricular pressure and rate pressure product compared to hearts perfused with pure Krebs-Henseleit (KH)-buffer. The capsules prevented the myocardium from functional fail when in their absence a noxious ischemia was observed. Capsules did not change rheological properties of KH-buffer and could repeatedly reload with oxygen. This albumin-derived perfluorocarbon-based artificial oxygen carrier preserved the function of rat hearts due to the transport of oxygen in a satisfactory manner. Because of these positive results, the functionality of the applied capsules should be verified in living animals.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Blood Substitutes
/
Albumins
/
Fluorocarbons
/
Heart
Limits:
Animals
Language:
En
Journal:
Artif Cells Nanomed Biotechnol
Year:
2017
Document type:
Article
Affiliation country:
Germany